Epigenetic Therapy Augments Classic Chemotherapy in Suppressing the Growth of 3D High-Grade Serous Ovarian Cancer Spheroids over an Extended Period of Time

por Michelle Bilbao, Chelsea Katz, Stephanie L. Kass, Devon Smith, Krystal Hunter, David Warshal, James K. Aikins, Olga Ostrovsky
Publicado 2021

Anti-Angiogenesis Maintenance Therapy in Newly Diagnosed and Relapsed Ovarian Cancer: A Meta-analysis of Phase III Randomized Controlled Trials

por Yizi Wang, Shitai Zhang, Zixuan Song, Ling Ouyang, Yan Li
Publicado 2021

Dermatomyositis and/or polymyositis as a paraneoplastic manifestation of ovarian cancer: a systematic review

por Victoria Psomiadou, Ioannis D. Gkegkes, Christos Iavazzo
Publicado 2021

Identification of 5-methylcytosine-related signature for predicting prognosis in ovarian cancer

por Wang,Lei, Gao,Song
Publicado 2021

Clinical value of bioelectrical properties of cancerous tissue in advanced epithelial ovarian cancer patients

por Paula Cunnea, Tommy Gorgy, Konstantinos Petkos, Sally A.N. Gowers, Haonan Lu, Cristina Morera, Wen Wu, Phillip Lawton, Katherine Nixon, Chi Leng Leong, Flavia Sorbi, Lavinia Domenici, Andrew Paterson, Ed Curry, Hani Gabra, Martyn G. Boutelle, Emmanuel M. Drakakis, Christina Fotopoulou
Publicado 2018

The association between lymph node metastases and long-term survival in patients with epithelial ovarian cancer

por Katarzyna Lepinay, Sebastian Szubert, Agnieszka Lewandowska, Tomasz Rajs, Krzysztof Koper, Agnieszka Koper, Grzegorz Panek, Zbigniew Kojs, Wojciech Rokita, Lukasz Wicherek
Publicado 2020

Selection and Characterization of Vimentin-Binding Aptamer Motifs for Ovarian Cancer

por Andrea M. Costello, Miguel-Angel Elizondo-Riojas, Xin Li, David E. Volk, Anil K. Pillai, Hongyu Wang
Publicado 2021

Assessment of prognostic value of tissue inhibitors of metalloproteinase 3 (TIMP3) protein in ovarian cancer

por Sahar Hakamy, Mourad Assidi, Mohammad A. Jafri, Taoufik Nedjadi, Heba Alkhatabi, Abrar Al-Qahtani, Jaudah Al-Maghrabi, Khalid Sait, Mohammed Al-Qahtani, Abdelbaset Buhmeida, Adeel Chaudhary
Publicado 2021

Resveratrol Targets a Variety of Oncogenic and Oncosuppressive Signaling for Ovarian Cancer Prevention and Treatment

por Xue-Ling Xu, Shou-Long Deng, Zheng-Xing Lian, Kun Yu
Publicado 2021

Downregulation of TGF-β1 suppressed proliferation and increased chemosensitivity of ovarian cancer cells by promoting BRCA1/Smad3 signaling

por Wang,Yanqiu, Xiang,Jun, Wang,Jianjun, Ji,Yazhong
Publicado 2018

Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1

por Zhang,Yun, Ai,Hao, Fan,Xue, Chen,Suxian, Wang,Yadi, Liu,Lili
Publicado 2020

MicroRNA-663 facilitates the growth, migration and invasion of ovarian cancer cell by inhibiting TUSC2

por Xie,Hui Hui, Huan,Wen Ting, Han,Jiang Qiong, Ren,Wei Ru, Yang,Li Hua
Publicado 2019

Prognostic value of E-Cadherin and its tumor suppressor role in Saudi women with advanced epithelial ovarian cancer

por Mourad Assidi, Mohammad Alam Jafri, Muhammad Abu-Elmagd, Peter N. Pushparaj, Salina Saddick, Safia Messaoudi, Heba Alkhatabi, Jaudah Al-Maghrabi, Nisreen Anfinan, Maram Sait, Abdelfatteh El Omri, Hesham Sait, Hussain Basalamah, Abdelbaset Buhmeida, Khalid Sait
Publicado 2021

Pain Control, Acceptance and Adjustment to the Disease among Patients with Ovarian, Endometrial and Breast Cancer in Poland

por Aleksandra Czerw, Urszula Religioni, Katarzyna Sygit, Agnieszka Nieradko-Heluszko, Dominika Mękal, Olga Partyka, Marcin Mikos, Mateusz Eid, Łukasz Strzępek, Tomasz Banaś
Publicado 2021

MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2

por Xing,Feng, Song,Zhijiao, He,Yuanying
Publicado 2018

Identification of keygenes, miRNAs and miRNA-mRNA regulatory pathways for chemotherapy resistance in ovarian cancer

por Wenwen Wang, Wenwen Zhang, Yuanjing Hu
Publicado 2021

The clinical and pathological characteristics and survival of patients with advanced ovarian cancer

por Popović Miroslav, Milić-Radić Tanja, Cerić-Banićević Arnela
Publicado 2021

Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment

por Hu Y, Ran M, Wang B, Lin Y, Cheng Y, Zheng S
Publicado 2020

DIFFERENTIATION- AND ACTIVATION-ASSOCIATED MARKERS OF PERIPHERAL BLOOD LYMPHOCYTES IN THE PATIENTS WITH OVARIAN CANCER IN THE COURSE OF TUMOR PROGRESSION

por I. I. Antoneeva
Publicado 2014

Breast Carcinomatous Lymphangitis as an Unusual Presentation of Ovarian Cancer

por Barbara Muoio, Giorgio Treglia, Paola Migliora, Maria Del Grande
Publicado 2021